Overall, 96% of patients enrolled in the subgroups α and 87.5% of patients in subgroups β have declared full satisfaction of the visual performance achieved with new prescription. This difference was statistically significant. This difference was more relevant in the most complex patient groups (pseudophakic (Group C) and antimetropic (Group D)).
Considering three main cohorts of patients satisfaction in the quality of vision achieved by patients who had abandoned progressive lenses since dissatisfied was double in subcategories α (86%) compared to those β (43%).
In this cohort it belonged all of antimetropic patients and approximately 2/3 of the patients strongly anisometropi.
Opticians who have collaborated in this study reported that they had found great satisfaction from clients who could choose custom progressive lenses using the SBM Sistem software.